US Stock MarketDetailed Quotes

Applied Therapeutics (APLT)

Watchlist
  • 0.1060
  • +0.0046+4.54%
Close Jan 22 15:59 ET
  • 0.1042
  • -0.0018-1.70%
Pre 08:31 ET
15.30MMarket Cap-1.06P/E (TTM)

Applied Therapeutics (APLT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
719.67%1M
0
0
-95.45%455K
0
122K
144K
-98.22%190K
9.99M
-667K
Operating revenue
719.67%1M
--0
--0
-95.45%455K
--0
--122K
--144K
-98.22%190K
--9.99M
---667K
Cost of revenue
Gross profit
Operating expense
-36.49%18.97M
12.21%23.1M
19.93%25.53M
40.56%104.75M
62.34%33.02M
92.74%29.87M
19.84%20.58M
-1.09%21.28M
-10.15%74.53M
7.22%20.34M
Selling and administrative expenses
-37.71%9.37M
24.53%13.18M
95.10%17.69M
171.59%56.01M
323.32%21.33M
219.26%15.04M
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
-General and administrative expense
-37.71%9.37M
24.53%13.18M
95.10%17.69M
171.59%56.01M
323.32%21.33M
219.26%15.04M
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
Research and development costs
-35.25%9.6M
-0.81%9.92M
-35.85%7.84M
-9.57%48.74M
-23.58%11.7M
37.49%14.83M
-15.81%10M
-23.33%12.22M
-3.11%53.91M
26.55%15.3M
Operating profit
39.59%-17.97M
-13.00%-23.1M
-21.01%-25.53M
-61.62%-104.3M
-57.19%-33.02M
-91.95%-29.74M
-19.00%-20.44M
-94.26%-21.09M
22.20%-64.54M
-10.73%-21.01M
Net non-operating interest income expense
-89.39%144K
-42.04%364K
5.97%621K
157.58%3.53M
173.30%962K
246.17%1.36M
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
Non-operating interest income
-89.39%144K
-42.04%364K
5.97%621K
157.58%3.53M
173.30%962K
246.17%1.36M
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
Other net income (expense)
97.10%-1.17M
-93.82%1.4M
104.85%3.08M
91.42%-4.86M
546.85%76.07M
-47.45%-40.21M
277.30%22.71M
-12,786.20%-63.43M
-23,192.18%-56.6M
-498.48%-17.02M
Gain on sale of security
94.10%-2.37M
-93.68%1.44M
104.90%3.1M
91.55%-4.78M
548.43%76.06M
-47.32%-40.18M
277.63%22.74M
-13,619.19%-63.41M
-85,616.67%-56.57M
-498.64%-16.96M
Special income (charges)
--1.21M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
---1.21M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
66.67%-7K
2.94%-33K
3.85%-25K
-185.19%-77K
106.56%4K
-310.00%-21K
-580.00%-34K
-183.87%-26K
84.75%-27K
-458.82%-61K
Income before tax
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Income tax
Net income
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Net income continuous Operations
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Minority interest income
Net income attributable to the parent company
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.31%-18.99M
-836.02%-21.33M
74.00%-21.83M
11.81%-105.62M
216.79%44.01M
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
Basic earnings per share
72.92%-0.13
-850.00%-0.15
77.61%-0.15
46.48%-0.76
200.00%0.33
-2.13%-0.48
105.41%0.02
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
Diluted earnings per share
72.92%-0.13
-15.38%-0.15
77.61%-0.15
46.48%-0.76
200.00%0.33
-2.13%-0.48
64.86%-0.13
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 719.67%1M00-95.45%455K0122K144K-98.22%190K9.99M-667K
Operating revenue 719.67%1M--0--0-95.45%455K--0--122K--144K-98.22%190K--9.99M---667K
Cost of revenue
Gross profit
Operating expense -36.49%18.97M12.21%23.1M19.93%25.53M40.56%104.75M62.34%33.02M92.74%29.87M19.84%20.58M-1.09%21.28M-10.15%74.53M7.22%20.34M
Selling and administrative expenses -37.71%9.37M24.53%13.18M95.10%17.69M171.59%56.01M323.32%21.33M219.26%15.04M99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M
-General and administrative expense -37.71%9.37M24.53%13.18M95.10%17.69M171.59%56.01M323.32%21.33M219.26%15.04M99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M
Research and development costs -35.25%9.6M-0.81%9.92M-35.85%7.84M-9.57%48.74M-23.58%11.7M37.49%14.83M-15.81%10M-23.33%12.22M-3.11%53.91M26.55%15.3M
Operating profit 39.59%-17.97M-13.00%-23.1M-21.01%-25.53M-61.62%-104.3M-57.19%-33.02M-91.95%-29.74M-19.00%-20.44M-94.26%-21.09M22.20%-64.54M-10.73%-21.01M
Net non-operating interest income expense -89.39%144K-42.04%364K5.97%621K157.58%3.53M173.30%962K246.17%1.36M53.92%628K165.16%586K100.29%1.37M29.89%352K
Non-operating interest income -89.39%144K-42.04%364K5.97%621K157.58%3.53M173.30%962K246.17%1.36M53.92%628K165.16%586K100.29%1.37M29.89%352K
Other net income (expense) 97.10%-1.17M-93.82%1.4M104.85%3.08M91.42%-4.86M546.85%76.07M-47.45%-40.21M277.30%22.71M-12,786.20%-63.43M-23,192.18%-56.6M-498.48%-17.02M
Gain on sale of security 94.10%-2.37M-93.68%1.44M104.90%3.1M91.55%-4.78M548.43%76.06M-47.32%-40.18M277.63%22.74M-13,619.19%-63.41M-85,616.67%-56.57M-498.64%-16.96M
Special income (charges) --1.21M------------------0----------------
-Less:Other special charges ---1.21M------------------------------------
Other non- operating income (expenses) 66.67%-7K2.94%-33K3.85%-25K-185.19%-77K106.56%4K-310.00%-21K-580.00%-34K-183.87%-26K84.75%-27K-458.82%-61K
Income before tax 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Income tax
Net income 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Net income continuous Operations 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Minority interest income
Net income attributable to the parent company 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.31%-18.99M-836.02%-21.33M74.00%-21.83M11.81%-105.62M216.79%44.01M-61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M
Basic earnings per share 72.92%-0.13-850.00%-0.1577.61%-0.1546.48%-0.76200.00%0.33-2.13%-0.48105.41%0.02-272.22%-0.6734.86%-1.42-106.25%-0.33
Diluted earnings per share 72.92%-0.13-15.38%-0.1577.61%-0.1546.48%-0.76200.00%0.33-2.13%-0.4864.86%-0.13-272.22%-0.6734.86%-1.42-106.25%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More